TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Pharma Compliance AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
49
|
72
|
79 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
12
|
45
|
48 |
| EBITDA |
11
|
45
|
48 |
| Total assets |
169
|
175
|
171 |
| Current assets |
75
|
103
|
93 |
| Current liabilities |
12
|
9
|
12 |
| Equity capital |
157
|
165
|
159 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.9%
|
94.3%
|
93.0% |
| Turnover per employee |
49
|
72
|
79 |
| Profit as a percentage of turnover |
24.5%
|
62.5%
|
60.8% |
| Return on assets (ROA) |
7.1%
|
25.7%
|
28.1% |
| Current ratio |
625.0%
|
1144.4%
|
775.0% |
| Return on equity (ROE) |
7.6%
|
27.3%
|
30.2% |
| Change turnover |
-23
|
-1
|
-16 |
| Change turnover % |
-33%
|
-1%
|
-17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.